- 2.8Impact Factor
- 5.5CiteScore
- 15 daysTime to First Decision
Genetic Insights and Molecular Pathways in Alzheimer's Disease: Unveiling the Complexity of Neurodegeneration
This special issue belongs to the section “Human Genomics and Genetic Diseases“.
Special Issue Information
Dear Colleagues,
Alzheimer’s disease (AD) is a multifactorial neurodegenerative disorder characterized by progressive cognitive decline and complex molecular underpinnings. Genetic factors, including mutations in APP, PSEN1, and PSEN2, as well as risk variants such as APOE ε4, play pivotal roles in amyloid-β aggregation and tau pathology. Recent genome-wide association studies (GWAS) have uncovered additional susceptibility loci linked to immune response, lipid metabolism, and synaptic function, highlighting the polygenic nature of AD. At the molecular level, dysregulation of neuroinflammatory pathways, mitochondrial dysfunction, oxidative stress, and impaired proteostasis converge to accelerate neuronal loss. Advances in transcriptomics, epigenetics, and multi-omics approaches are further elucidating the interplay between genetic predisposition and environmental factors, offering insights into disease heterogeneity and therapeutic targets. Understanding these interconnected pathways is essential for the development of personalized medicine strategies aimed at early detection, prevention, and precision therapies in AD.
Dr. Marta Rusek
Dr. Alessandro Romano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Alzheimer’s disease
- neurodegeneration
- amyloid-β pathology
- tau pathology
- APOE ε4
- APP
- PSEN1
- PSEN2
- GWAS
- neuroinflammation
- mitochondrial dysfunction
- oxidative stress
- proteostasis
- precision medicine
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

